SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
------------------------------
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
(Amendment No. 1)1
Select Medical Corporation
-----------------------------------------------------------------------
(Name of Issuer)
Common Stock, $.01 par value
-----------------------------------------------------------------------
(Title of Class of Securities)
816196 10 9
-----------------------------------------------------------------------
(CUSIP Number)
December 31, 2001
-----------------------------------------------------------------------
Date of Event Which Requires Filing of this Statement
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[ ] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[X] Rule 13d-1(d)
--------
1The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page. The information required on
the remainder of this cover page shall not be deemed to be "filed" for the
purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise
subject to the liabilities of that section of the Act but shall be subject to
all other provisions of the Act.
CUSIP No. 816196 10 9 Page 2 of 6 Pages
------------------------------------------------------------------------------
1) Name of Reporting Person Welsh, Carson,
I.R.S. Identification Anderson & Stowe
No. of Above Person VII, L.P.
(Entities Only)
------------------------------------------------------------------------------
2) Check the Appropriate Box (a) [ X ]
if a Member of a Group (b) [ ]
------------------------------------------------------------------------------
3) SEC Use Only
------------------------------------------------------------------------------
4) Citizenship or Place Delaware
of Organization
------------------------------------------------------------------------------
Number of 5) Sole Voting 9,642,379 shares
Shares Beneficially Power of Common Stock
Owned by Each (including shares
Reporting Person issuable upon exercise
With: of warrants)
-------------------------------------------------
6) Shared Voting
Power -0-
-------------------------------------------------
7) Sole Disposi- 9,642,379 shares of
tive Power Common Stock
(including shares
issuable upon exercise
of warrants)
-------------------------------------------------
8) Shared Dis-
positive Power -0-
-------------------------------------------------
9) Aggregate Amount Beneficially 9,642,379 shares of
Owned by Each Reporting Person Common Stock
(including shares
issuable upon exercise
of warrants)
------------------------------------------------------------------------------
10) Check if the Aggregate
Amount in Row (9)
Excludes Certain Shares
------------------------------------------------------------------------------
11) Percent of Class
Represented by 20.7%
Amount in Row (9)
------------------------------------------------------------------------------
12) Type of Reporting
Person PN
CUSIP No. 816196 10 9 Page 3 of 6 Pages
------------------------------------------------------------------------------
1) Name of Reporting Person WCAS Capital
I.R.S. Identification Partners III, L.P.
No. of Above Person
(Entities Only)
------------------------------------------------------------------------------
2) Check the Appropriate Box (a) [ X ]
if a Member of a Group (b) [ ]
------------------------------------------------------------------------------
3) SEC Use Only
------------------------------------------------------------------------------
4) Citizenship or Place Delaware
of Organization
------------------------------------------------------------------------------
Number of 5) Sole Voting 2,294,007 shares
Shares Beneficially Power of Common Stock
Owned by Each (including shares
Reporting Person issuable upon exercise
With: of warrants)
-------------------------------------------------
6) Shared Voting
Power -0-
-------------------------------------------------
7) Sole Disposi- 2,294,007 shares of
tive Power Common Stock
(including shares
issuable upon exercise
of warrants)
-------------------------------------------------
8) Shared Dis-
positive Power -0-
-------------------------------------------------
9) Aggregate Amount Beneficially 2,294,007 shares of
Owned by Each Reporting Person Common Stock
(including shares
issuable upon exercise
of warrants)
------------------------------------------------------------------------------
10) Check if the Aggregate
Amount in Row (9)
Excludes Certain Shares
------------------------------------------------------------------------------
11) Percent of Class
Represented by 5.0%
Amount in Row (9)
------------------------------------------------------------------------------
12) Type of Reporting
Person PN
CUSIP No. 816196 10 9 Page 4 of 6 Pages
------------------------------------------------------------------------------
1) Name of Reporting Person WCAS Healthcare
I.R.S. Identification Partners, L.P.
No. of Above Person
(Entities Only)
------------------------------------------------------------------------------
2) Check the Appropriate Box (a) [ X ]
if a Member of a Group (b) [ ]
------------------------------------------------------------------------------
3) SEC Use Only
------------------------------------------------------------------------------
4) Citizenship or Place Delaware
of Organization
------------------------------------------------------------------------------
Number of 5) Sole Voting 427,511 shares
Shares Beneficially Power of Common Stock
Owned by Each
Reporting Person
With:
-------------------------------------------------
6) Shared Voting
Power -0-
-------------------------------------------------
7) Sole Disposi- 427,511 shares of
tive Power Common Stock
-------------------------------------------------
8) Shared Dis-
positive Power -0-
-------------------------------------------------
9) Aggregate Amount Beneficially 427,511 shares of
Owned by Each Reporting Person Common Stock
------------------------------------------------------------------------------
10) Check if the Aggregate
Amount in Row (9)
Excludes Certain Shares
------------------------------------------------------------------------------
11) Percent of Class
Represented by 0.9%
Amount in Row (9)
------------------------------------------------------------------------------
12) Type of Reporting
Person PN
CUSIP No. 816196 10 9 Page 5 of 6 Pages
Amendment No. 1 to Schedule 13G
-------------------------------
Reference is hereby made to the statement on Schedule 13G filed with
the Securities and Exchange Commission on January 22, 2002 (the "Schedule 13G").
Terms defined in the Schedule 13G are used herein as so defined. This Amendment
No. 1 is being filed solely to correct certain information provided in the
Schedule 13G with respect to the Reporting Persons' ownership as of December 31,
2001.
The following Items of the Schedule 13G are amended and restated as
follows:
Item 4 - Ownership.
(a) Amount Beneficially Owned:
WCAS VII: 9,642,379 shares of Common Stock (including shares
issuable upon exercise of warrants)
WCAS CP III: 2,294,007 shares of Common Stock (including
shares issuable upon exercise of warrants)
WCAS HP: 427,511 shares of Common Stock
(b) Percent of Class:
WCAS VII: 20.7%
WCAS CP III: 5.0%
WCAS HP: 0.9%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote:
WCAS VII: 9,642,379 shares of Common Stock (including shares
issuable upon exercise of warrants)
WCAS CP III: 2,294,007 shares of Common Stock (including
shares issuable upon exercise of warrants)
WCAS HP: 427,511 shares of Common Stock
(ii) shared power to vote or to direct the vote: -0-
(iii) sole power to dispose or to direct the disposition of:
WCAS VII: 9,642,379 shares of Common Stock (including shares
issuable upon exercise of warrants)
WCAS CP III: 2,294,007 shares of Common Stock (including
shares issuable upon exercise of warrants)
WCAS HP: 427,511 shares of Common Stock
(iv) shared power to dispose or to direct the
disposition of: -0-
CUSIP No. 816196 10 9 Page 6 of 6 Pages
Signature:
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
WELSH, CARSON, ANDERSON & STOWE VII, L.P.
By: WCAS VII Partners, L.P., General
Partner
By /s/ Jonathan M. Rather
--------------------------------------
General Partner
WCAS CAPITAL PARTNERS III, L.P.
By: WCAS CP III Associates, L.L.C., General
Partner
By /s/ Jonathan M. Rather
--------------------------------------
Managing Member
WCAS HEALTHCARE PARTNERS, L.P.
By: WCAS HP Partners, General Partner
By /s/ Jonathan M. Rather
-------------------------------------
Attorney-in-Fact
Date: February 14, 2002